{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:45:31Z","timestamp":1740098731994,"version":"3.37.3"},"publisher-location":"Cham","reference-count":205,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319456492"},{"type":"electronic","value":"9783319456515"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/10_2016_6","type":"book-chapter","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T07:59:40Z","timestamp":1468828780000},"page":"433-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anaerobes as Sources of Bioactive Compounds and Health Promoting Tools"],"prefix":"10.1007","author":[{"given":"Gashaw","family":"Mamo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,19]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1126\/science.1079857","volume":"299","author":"JO Hill","year":"2003","unstructured":"Hill JO, Wyatt HR, Reed GW, Peters JC (2003) Obesity and the environment: where do we go from here? Science 299:853\u2013855","journal-title":"Science"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.4065\/mcp.2010.0444","volume":"85","author":"N Owen","year":"2010","unstructured":"Owen N, Sparling PB, Healy GN, Dunstan DW, Matthews CE (2010) Sedentary behavior: emerging evidence for a new health risk. Mayo Clin Proc 85:1138\u20131141","journal-title":"Mayo Clin Proc"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.3390\/molecules20045286","volume":"20","author":"A Penesyan","year":"2015","unstructured":"Penesyan A, Gillings M, Paulsen IT (2015) Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities. Molecules 20:5286\u20135298","journal-title":"Molecules"},{"key":"6_CR4","unstructured":"Laxminarayan R, Malani A (2007) Extending the cure: policy responses to the growing threat of antibiotic resistance. Earthscan"},{"key":"6_CR5","unstructured":"WHO (2010) Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response"},{"key":"6_CR6","unstructured":"WHO (2011) Antimicrobial resistance. http:\/\/www.who.int\/mediacentre\/factsheets\/fs194\/en\/"},{"key":"6_CR7","first-page":"210","volume-title":"The resistance phenomenon in microbes and infectious disease vectors: implications for human health and strategies for containment","author":"J Gerberding","year":"2003","unstructured":"Gerberding J (2003) The resistance phenomenon in microbes and infectious disease vectors: implications for human health and strategies for containment. National Academic Press, Washington, pp 210\u2013215"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1155\/2006\/707296","volume":"17","author":"J Davies","year":"2006","unstructured":"Davies J (2006) Where have all the antibiotics gone? Can J Infect Dis Med Microbiol 17:287\u2013290","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","volume":"11","author":"JW Scannell","year":"2012","unstructured":"Scannell JW, Blanckley A, Boldon H, Warrington B (2012) Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 11:191\u2013200","journal-title":"Nat Rev Drug Discov"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1086\/524891","volume":"46","author":"B Spellberg","year":"2008","unstructured":"Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J (2008) The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 46:155\u2013164","journal-title":"Clin Infect Dis"},{"key":"6_CR11","volume-title":"Antimicrobial resistance: global report on surveillance","author":"WHO","year":"2014","unstructured":"WHO (2014) Antimicrobial resistance: global report on surveillance. World Health Organization, Geneva"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"DJ Payne","year":"2007","unstructured":"Payne DJ, Gwynn MN, Holmes DJ, Pompliano D (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6:29\u201340","journal-title":"Nat Rev Drug Discov"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.drup.2011.01.006","volume":"14","author":"AD So","year":"2011","unstructured":"So AD, Gupta N, Brahmachari SK, Chopra I, Munos B, Nathan C, Outterson K, Paccaud JP, Payne DJ, Peeling RW, Spigelman M, Weigelt J (2011) Towards new business models for R&D for novel antibiotics. Drug Resist Updat 14:88\u201394","journal-title":"Drug Resist Updat"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijmm.2013.08.011","volume":"304","author":"SJ Pidot","year":"2014","unstructured":"Pidot SJ, Coyne S, Kloss F, Hertweck C (2014) Antibiotics from neglected bacterial sources. Int J Med Microbiol 304:14\u201322","journal-title":"Int J Med Microbiol"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ja.2005.1","volume":"58","author":"J B\u00e9rdy","year":"2005","unstructured":"B\u00e9rdy J (2005) Bioactive microbial metabolites. J Antibiot 58:1\u201326","journal-title":"J Antibiot"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","volume":"1830","author":"GM Cragg","year":"2013","unstructured":"Cragg GM, Newman DJ (2013) Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 1830:3670\u20133695","journal-title":"Biochim Biophys Acta"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/np200906s","volume":"75","author":"DJ Newman","year":"2012","unstructured":"Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311\u2013335","journal-title":"J Nat Prod"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF02796164","volume":"48","author":"JG Morris","year":"1994","unstructured":"Morris JG (1994) Obligately anaerobic bacteria in biotechnology. Appl Biochem Biotechnol 48:75\u2013106","journal-title":"Appl Biochem Biotechnol"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tibtech.2010.12.007","volume":"29","author":"RA Weusthuis","year":"2011","unstructured":"Weusthuis RA, Lamot I, van der Oost J, Sanders JPM (2011) Microbial production of bulk chemicals: development of anaerobic processes. Trends Biotechnol 29:153\u2013158","journal-title":"Trends Biotechnol"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1001\/jama.2008.655","volume":"300","author":"AS Bernstein","year":"2008","unstructured":"Bernstein AS, Ludwig DS (2008) The importance of biodiversity to medicine. JAMA 300:2297\u20132299","journal-title":"JAMA"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.bmcl.2013.12.059","volume":"24","author":"DG Brown","year":"2014","unstructured":"Brown DG, Lister T, May-Dracka TL (2014) New natural products as new leads for antibacterial drug discovery. Bioorg Med Chem Lett 24:413\u2013418","journal-title":"Bioorg Med Chem Lett"},{"key":"6_CR22","first-page":"27","volume":"41","author":"S Hussain","year":"2012","unstructured":"Hussain S, Fareed S, Ansari S, Khan S (2012) Marine natural products: a lead for anti cancer. Indian J Geo Mar Sci 41:27\u201339","journal-title":"Indian J Geo Mar Sci"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev.micro.56.012302.161024","volume":"56","author":"MA Riley","year":"2002","unstructured":"Riley MA, Wertz JE (2002) Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 56:117\u2013137","journal-title":"Annu Rev Microbiol"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1039\/c0ob00139b","volume":"8","author":"L Cascales","year":"2010","unstructured":"Cascales L, Craik DJ (2010) Naturally occurring circular proteins: distribution, biosynthesis and evolution. Org Biomol Chem 8:5035\u20135047","journal-title":"Org Biomol Chem"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/bip.21416","volume":"94","author":"JD Walton","year":"2010","unstructured":"Walton JD, Hallen-Adams HE, Luo H (2010) Ribosomal biosynthesis of the cyclic peptide toxins of Amanita mushrooms. Biopolymers 94:659\u2013664","journal-title":"Biopolymers"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0168-1605(93)90178-J","volume":"19","author":"K Arihara","year":"1993","unstructured":"Arihara K, Cassens RG, Luchansky JB (1993) Characterisation of bacteriocins from Enterococcus faecium with activity against Listeria monocytogenes. Int J Food Microbiol 19:123\u2013134","journal-title":"Int J Food Microbiol"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1471-0307.12188","volume":"68","author":"EM Balciunas","year":"2015","unstructured":"Balciunas EM, Al Arni S, Converti A, Leblanc JG, Oliveira RPDS (2015) Production of bacteriocin\u2010like inhibitory substances (BLIS) by Bifidobacterium lactis using whey as a substrate. Int J Dairy Technol 68:1\u20136","journal-title":"Int J Dairy Technol"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.3168\/jds.S0022-0302(93)77574-8","volume":"76","author":"SF Barefoot","year":"1993","unstructured":"Barefoot SF, Nettles CG (1993) Antibiosis revisited: bacteriocins produced by dairy starter cultures. J Dairy Sci 76:2366\u20132379","journal-title":"J Dairy Sci"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.anaerobe.2014.02.002","volume":"27","author":"A Chakchouk-Mtibaa","year":"2014","unstructured":"Chakchouk-Mtibaa A, Elleuch L, Smaoui S, Najah S, Sellem I, Abdelkafi S, Mellouli L (2014) An antilisterial bacteriocin BacFL31 produced by Enterococcus faecium FL31 with a novel structure containing hydroxyproline residues. Anaerobe 27:1\u20136","journal-title":"Anaerobe"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/978-1-4615-7087-5_17","volume-title":"Genetics and molecular biology of anaerobic bacteria","author":"ST Cole","year":"1993","unstructured":"Cole ST, Garnier T (1993) Molecular genetic studies of UV-inducible bacteriocin production in Clostridium perfringens. In: Sebald M (ed) Genetics and molecular biology of anaerobic bacteria. Springer, New York, pp 248\u2013254"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1139\/m76-151","volume":"22","author":"WG Iverson","year":"1976","unstructured":"Iverson WG, Mills NF (1976) Bacteriocins of Streptococcus bovis. Can J Microbiol 22:1040\u20131047","journal-title":"Can J Microbiol"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1472-765X.1993.tb01413.x","volume":"16","author":"A Laukov\u00e1","year":"1993","unstructured":"Laukov\u00e1 A, Marekov\u00e1 M, Javorsky P (1993) Detection and antimicrobial spectrum of a bacteriocin-like substance produced by Enterococcus faecium CCM4231. Lett Appl Microbiol 16:257\u2013260","journal-title":"Lett Appl Microbiol"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2174\/1389203043379567","volume":"5","author":"M Maqueda","year":"2004","unstructured":"Maqueda M, Galvez A, Bueno M, Sanchez-Barrena MJ, Gonzalez C, Albert A, Rico M, Valdivia E (2004) Peptide AS-48: prototype of a new class of cyclic bacteriocins. Curr Protein Pept Sci 5:399\u2013416","journal-title":"Curr Protein Pept Sci"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/BF01030755","volume":"12","author":"J Meghrous","year":"1990","unstructured":"Meghrous J, Euloge P, Junelles AM, Ballongue J, Petitdemange H (1990) Screening of Bifidobacterium strains for bacteriocin production. Biotechnol Lett 12:575\u2013580","journal-title":"Biotechnol Lett"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1139\/m93-023","volume":"39","author":"CMS Miranda","year":"1993","unstructured":"Miranda CMS, Farias LM, Carvalho MAR, Damasceno CAV, Totola AH, Tavares CAP, Cisalpino EO, Vieira EC (1993) Purification and partial characterization of a bacteriocin isolated from Bacteroides ovatus H47. Can J Microbiol 39:169\u2013174","journal-title":"Can J Microbiol"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1128\/AAC.25.2.253","volume":"25","author":"JA Southern","year":"1984","unstructured":"Southern JA, Katz W, Woods DR (1984) Purification and properties of a cell-bound bacteriocin from a Bacteroides fragilis strain. Antimicrob Agents Chemother 25:253\u2013257","journal-title":"Antimicrob Agents Chemother"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1472-765X.1991.tb00546.x","volume":"12","author":"T Toba","year":"1991","unstructured":"Toba T, Yoshioka E, Itoh T (1991) Potential of Lactobacillus gasseri isolated from infant faeces to produce bacteriocin. Lett Appl Microbiol 12:228\u2013231","journal-title":"Lett Appl Microbiol"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.anaerobe.2014.03.001","volume":"27","author":"P Wannun","year":"2014","unstructured":"Wannun P, Piwat S, Teanpaisan R (2014) Purification and characterization of bacteriocin produced by oral Lactobacillus paracasei SD1. Anaerobe 27:17\u201321","journal-title":"Anaerobe"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro2937","volume":"11","author":"PD Cotter","year":"2013","unstructured":"Cotter PD, Ross RP, Hill C (2013) Bacteriocins \u2013 a viable alternative to antibiotics? Nat Rev Microbiol 11:95\u2013105","journal-title":"Nat Rev Microbiol"},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.apcbee.2012.06.010","volume":"2","author":"MP Zacharof","year":"2012","unstructured":"Zacharof MP, Lovitt RW (2012) Bacteriocins produced by lactic acid bacteria: a review article. APCBEE Procedia 2:50\u201356","journal-title":"APCBEE Procedia"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/nrmicro1273-c1","volume":"2006","author":"NCK Heng","year":"2006","unstructured":"Heng NCK, Tagg JR (2006) What\u2019s in a name? Class distinction for bacteriocins. Nat Rev Microbiol 2006:4. doi: 10.1038\/nrmicro1273-c1","journal-title":"Nat Rev Microbiol"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00018-011-0724-4","volume":"68","author":"M Sanchez-Hidalgo","year":"2011","unstructured":"Sanchez-Hidalgo M, Montalban-Lopez M, Cebrian R, Valdivia E, Martinez-Bueno M, Maqueda M (2011) AS-48 bacteriocin: close to perfection. Cell Mol Life Sci 68:2845\u20132857","journal-title":"Cell Mol Life Sci"},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrmicro1273","volume":"3","author":"PD Cotter","year":"2005","unstructured":"Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3:777\u2013788","journal-title":"Nat Rev Microbiol"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/476393a","volume":"476","author":"M Blaser","year":"2011","unstructured":"Blaser M (2011) Antibiotic overuse: stop the killing of beneficial bacteria. Nature 476:393\u2013394","journal-title":"Nature"},{"key":"6_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrmicro2536","volume":"9","author":"BP Willing","year":"2011","unstructured":"Willing BP, Russell SL, Finlay BB (2011) Shifting the balance: antibiotic effects on host\u2013microbiota mutualism. Nat Rev Microbiol 9:233\u2013243","journal-title":"Nat Rev Microbiol"},{"key":"6_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.idairyj.2007.11.009","volume":"18","author":"A Sobrino-Lopez","year":"2008","unstructured":"Sobrino-Lopez A, Martin-Belloso O (2008) Use of nisin and other bacteriocins for preservation of dairy products. Int Dairy J 18:329\u2013343","journal-title":"Int Dairy J"},{"key":"6_CR47","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1007\/s13197-014-1666-2","volume":"52","author":"CV Prud\u00eancio","year":"2015","unstructured":"Prud\u00eancio CV, dos Santos MT, Vanetti MCD (2015) Strategies for the use of bacteriocins in Gram-negative bacteria: relevance in food microbiology. J Food Sci Technol 52:5408\u20135417","journal-title":"J Food Sci Technol"},{"key":"6_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1871526514666140522113337","volume":"15","author":"H Ghodhbane","year":"2015","unstructured":"Ghodhbane H, Elaidi S, Sabatier JM, Achour S, Benhmida J, Regaya I (2015) Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infections. Infect Disord Drug Targets 15:2\u201312","journal-title":"Infect Disord Drug Targets"},{"key":"6_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/157016309787581075","volume":"6","author":"C Piper","year":"2009","unstructured":"Piper C, Cotter PD, Ross RP, Hill C (2009) Discovery of medically significant lantibiotics. Curr Drug Discov Technol 6:1\u201318","journal-title":"Curr Drug Discov Technol"},{"key":"6_CR50","doi-asserted-by":"publisher","first-page":"12661","DOI":"10.1021\/bi801597b","volume":"47","author":"CJ Arnusch","year":"2008","unstructured":"Arnusch CJ, Bonvin AM, Verel AM, Jansen WT, Liskamp RM, de Kruijff B, Pieters RJ, Breukink E (2008) The vancomycin-nisin(1\u201312) hybrid restores activity against vancomycin resistant enterococci. Biochemistry 47:12661\u201312663","journal-title":"Biochemistry"},{"key":"6_CR51","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1365-2958.2010.07406.x","volume":"78","author":"D Field","year":"2010","unstructured":"Field D, Hill C, Cotter PD, Ross RP (2010) The dawning of a \u2018Golden era\u2019 in lantibiotic bioengineering. Mol Microbiol 78:1077\u20131087","journal-title":"Mol Microbiol"},{"key":"6_CR52","doi-asserted-by":"publisher","first-page":"12024","DOI":"10.1021\/ja903239s","volume":"131","author":"MR Levengood","year":"2009","unstructured":"Levengood MR, Knerr PJ, Oman TJ, van der Donk WA (2009) In vitro mutasynthesis of lantibiotic analogues containing nonproteinogenic amino acids. J Am Chem Soc 131:12024\u201312025","journal-title":"J Am Chem Soc"},{"key":"6_CR53","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1021\/ja211088m","volume":"134","author":"AC Ross","year":"2012","unstructured":"Ross AC, McKinnie SM, Vederas JC (2012) The synthesis of active and stable diaminopimelate analogues of the lantibiotic peptide lactocin S. J Am Chem Soc 134:2008\u20132011","journal-title":"J Am Chem Soc"},{"key":"6_CR54","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/jac\/42.2.277","volume":"42","author":"BP Goldstein","year":"1998","unstructured":"Goldstein BP, Wei J, Greenberg K, Novick R (1998) Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J Antimicrob Chemother 42:277\u2013278","journal-title":"J Antimicrob Chemother"},{"key":"6_CR55","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2672.2012.05241.x","volume":"112","author":"AD Staden van","year":"2012","unstructured":"van Staden AD, Brand AM, Dicks LM (2012) Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo. J Appl Microbiol 112:831\u2013840","journal-title":"J Appl Microbiol"},{"key":"6_CR56","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/1082013208085933","volume":"13","author":"M Dziuba","year":"2007","unstructured":"Dziuba M, Darewicz M (2007) Food proteins as precursors of bioactive peptides \u2013 division into families. Food Sci Technol Int 13:393\u2013404","journal-title":"Food Sci Technol Int"},{"key":"6_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1874467211003030153","volume":"3","author":"AE Garcia","year":"2010","unstructured":"Garcia AE, Camarero JA (2010) Biological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics. Curr Mol Pharmacol 3:153\u2013163","journal-title":"Curr Mol Pharmacol"},{"key":"6_CR58","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.biocel.2005.06.011","volume":"37","author":"PB Pelegrini","year":"2005","unstructured":"Pelegrini PB, Franco OL (2005) Plant \u03b3-thionins: novel insights on the mechanism of action of a multi-functional class of defense proteins. Int J Biochem Cell Biol 37:2239\u20132253","journal-title":"Int J Biochem Cell Biol"},{"key":"6_CR59","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1128\/AEM.67.7.2883-2894.2001","volume":"67","author":"CP Selitrennikoff","year":"2001","unstructured":"Selitrennikoff CP (2001) Antifungal proteins. Appl Environ Microbiol 67:2883\u20132894","journal-title":"Appl Environ Microbiol"},{"key":"6_CR60","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1105\/tpc.7.5.573","volume":"7","author":"FR Terras","year":"1995","unstructured":"Terras FR, Eggermont K, Kovaleva V, Raikhel NV, Osborn RW, Kester A, Rees SB, Torrekens S, Van Leuven F, Vanderleyden J (1995) Small cysteine rich antifungal proteins from radish: their role in host defense. Plant Cell 7:573\u2013588","journal-title":"Plant Cell"},{"key":"6_CR61","first-page":"17","volume":"363","author":"H Korhonen","year":"2001","unstructured":"Korhonen H, Pihlanto-Lepp\u00e4l\u00e4 A (2001) Milk protein-derived bioactive peptides \u2013 novel opportunities for health promotion. IDF Bull 363:17\u201326","journal-title":"IDF Bull"},{"key":"6_CR62","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1128\/AEM.69.9.5297-5305.2003","volume":"69","author":"F Minervini","year":"2003","unstructured":"Minervini F, Algaron F, Rizzello CG, Fox PF, Monnet V, Gobbetti M (2003) Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Appl Environ Microbiol 69:5297\u20135305","journal-title":"Appl Environ Microbiol"},{"key":"6_CR63","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1128\/AEM.72.3.2260-2264.2006","volume":"72","author":"M Hayes","year":"2006","unstructured":"Hayes M, Ross RP, Fitzgerald GF, Hill C, Stanton C (2006) Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026. Appl Environ Microbiol 72:2260\u20132264","journal-title":"Appl Environ Microbiol"},{"key":"6_CR64","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/biot.200600246","volume":"2","author":"M Hayes","year":"2007","unstructured":"Hayes M, Ross RP, Fitzgerald GF, Hill C, Stanton C (2007) Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part I: overview. Biotechnol J 2:426\u2013434","journal-title":"Biotechnol J"},{"key":"6_CR65","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","volume":"43","author":"REW Hancock","year":"1999","unstructured":"Hancock REW, Chapple DS (1999) Peptide antibiotics. Antimicrob Agents Chemother 43:1317\u20131323","journal-title":"Antimicrob Agents Chemother"},{"key":"6_CR66","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.tibtech.2006.09.005","volume":"24","author":"S Mukherjee","year":"2006","unstructured":"Mukherjee S, Das P, Sen R (2006) Towards commercial production of microbial surfactants. Trends Biotechnol 24:509\u2013515","journal-title":"Trends Biotechnol"},{"key":"6_CR67","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/jac\/dkl024","volume":"57","author":"L Rodrigues","year":"2006","unstructured":"Rodrigues L, Banat IM, Teixeira J, Oliveira R (2006) Biosurfactants: potential applications in medicine. J Antimicrob Chemother 57:609\u2013618","journal-title":"J Antimicrob Chemother"},{"key":"6_CR68","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.biotechadv.2013.01.004","volume":"31","author":"SM Mandal","year":"2013","unstructured":"Mandal SM, Barbosa AEAD, Franco OL (2013) Lipopeptides in microbial infection control: scope and reality for industry. Biotechnol Adv 31:338\u2013345","journal-title":"Biotechnol Adv"},{"key":"6_CR69","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.tim.2007.12.009","volume":"16","author":"M Ongena","year":"2008","unstructured":"Ongena M, Jacques P (2008) Bacillus lipopeptides: versatile weapons for plant disease biocontrol. Trends Microbiol 16:115\u2013125","journal-title":"Trends Microbiol"},{"key":"6_CR70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijmm.2013.08.009","volume":"304","author":"T Schneider","year":"2014","unstructured":"Schneider T, M\u00fcller A, Miess H, Gross H (2014) Cyclic lipopeptides as antibacterial agents \u2013 potent antibiotic activity mediated by intriguing mode of actions. Int J Med Microbiol 304:37\u201343","journal-title":"Int J Med Microbiol"},{"key":"6_CR71","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2180-13-152","volume":"13","author":"SM Mandal","year":"2013","unstructured":"Mandal SM, Sharma S, Pinnaka AK, Kumari A, Korpole S (2013) Isolation and characterization of diverse antimicrobial lipopeptides produced by Citrobacter and Enterobacter. BMC Microbiol 13:152","journal-title":"BMC Microbiol"},{"key":"6_CR72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1099\/00207713-52-1-173","volume":"52","author":"K Denger","year":"2002","unstructured":"Denger K, Warthmann R, Ludwig W, Schink B (2002) Anaerophaga thermohalophila gen. nov., sp. nov., a moderately thermohalophilic, strictly anaerobic fermentative bacterium. Int J Syst Evol Microbiol 52:173\u2013178","journal-title":"Int J Syst Evol Microbiol"},{"key":"6_CR73","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.7164\/antibiotics.54.1054","volume":"54","author":"H Hashizume","year":"2001","unstructured":"Hashizume H, Igarashi M, Hattori S, Hori M, Hamada M, Takeuchi T (2001) Tripropeptins, novel antimicrobial agents produced by Lysobacter sp. I. Taxonomy, isolation and biological activities. J Antibiot 54:1054\u20131059","journal-title":"J Antibiot"},{"key":"6_CR74","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1128\/AAC.00931-06","volume":"51","author":"F Yu","year":"2007","unstructured":"Yu F, Zaleta-Rivera K, Zhu X, Huffman J, Millet JC, Harris SD, Yuen G, Li XC, Du L (2007) Structure and biosynthesis of heat-stable antifungal factor (HSAF), a broad-spectrum antimycotic with a novel mode of action. Antimicrob Agents Chemother 51:64\u201372","journal-title":"Antimicrob Agents Chemother"},{"key":"6_CR75","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1039\/c2np20064c","volume":"29","author":"Y Xie","year":"2012","unstructured":"Xie Y, Wright S, Shen Y, Du L (2012) Bioactive natural products from Lysobacter. Nat Prod Rep 29:1277\u20131287","journal-title":"Nat Prod Rep"},{"key":"6_CR76","doi-asserted-by":"publisher","first-page":"52","DOI":"10.7164\/antibiotics.57.52","volume":"57","author":"H Hashizume","year":"2004","unstructured":"Hashizume H, Hirosawa S, Sawa R, Muraoka Y, Ikeda D, Naganawa H, Igarashi M (2004) Tripropeptins novel antimicrobial agents produced by Lysobacter sp. II. Structure elucidation. J Antibiot 57:52\u201358","journal-title":"J Antibiot"},{"key":"6_CR77","doi-asserted-by":"publisher","first-page":"929","DOI":"10.7164\/antibiotics.51.929","volume":"51","author":"A Kato","year":"1998","unstructured":"Kato A, Nakaya S, Kokubo N, Aiba Y, Ohashi Y, Hirata H, Fujii K, Harada K (1998) A new anti-MRSA antibiotic complex, WAP-8294A. I. Taxonomy, isolation and biological activities. J Antibiot 51:929\u2013935","journal-title":"J Antibiot"},{"key":"6_CR78","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1128\/AEM.01244-09","volume":"75","author":"UF Sammer","year":"2009","unstructured":"Sammer UF, Volksch B, Mollmann U, Schmidtke M, Spiteller P, Spiteller M, Spiteller D (2009) 2-Amino-3-(oxirane-2,3-dicarboxamido)-propanoyl-valine, an effective peptide antibiotic from the epiphyte Pantoea agglomerans 48b\/90. Appl Environ Microbiol 75:7710\u20137717","journal-title":"Appl Environ Microbiol"},{"key":"6_CR79","doi-asserted-by":"publisher","first-page":"11912","DOI":"10.1021\/ja992790m","volume":"121","author":"SF Brady","year":"1999","unstructured":"Brady SF, Wright SA, Lee JC, Sutton AE, Zumoff CH, Wodzinsky RS, Beer SV, Clardy J (1999) Pantocin B, an antibiotic from Erwinia herbicola discovered by heterologous expression of cloned genes. J Am Chem Soc 121:11912\u201311913","journal-title":"J Am Chem Soc"},{"key":"6_CR80","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1094\/Phyto-78-746","volume":"78","author":"CA Ishimaru","year":"1988","unstructured":"Ishimaru CA, Klos EJ, Brubaker RR (1988) Multiple antibiotic production by Erwinia herbicola. Phytopathology 78:746\u2013750","journal-title":"Phytopathology"},{"key":"6_CR81","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1002\/anie.200351053","volume":"42","author":"M Jin","year":"2003","unstructured":"Jin M, Liu L, Wright SA, Beer SV, Clardy J (2003) Structural and functional analysis of pantocin A: an antibiotic from Pantoea agglomerans discovered by heterologous expression of cloned genes. Angew Chem Int Ed 42:2898\u20132901","journal-title":"Angew Chem Int Ed"},{"key":"6_CR82","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1002\/anie.200351054","volume":"42","author":"M Jin","year":"2003","unstructured":"Jin M, Wright SA, Beer SV, Clardy J (2003) The biosynthetic gene cluster of pantocin A provides insights into biosynthesis and a tool for screening. Angew Chem Int Ed 42:2902\u20132905","journal-title":"Angew Chem Int Ed"},{"key":"6_CR83","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1021\/ja00248a055","volume":"109","author":"A Fredenhagen","year":"1987","unstructured":"Fredenhagen A, Tamura SY, Kenny PTM, Komura H, Naya Y, Nakanishi K (1987) Andrimid, a new peptide antibiotic produced by an intracellular bacterial symbiont isolated from a brown planthopper. J Am Chem Soc 109:4409\u20134411","journal-title":"J Am Chem Soc"},{"key":"6_CR84","doi-asserted-by":"publisher","first-page":"26066","DOI":"10.1074\/jbc.M402989200","volume":"279","author":"C Freiberg","year":"2004","unstructured":"Freiberg C, Brunner NA, Schiffer G, Lampe T, Pohlmann J, Brands M, Raabe M, Habich D, Ziegelbauer K (2004) Identification and characterization of the first class of potent bacterial acetyl-CoA carboxylase inhibitors with antibacterial activity. J Biol Chem 279:26066\u201326073","journal-title":"J Biol Chem"},{"key":"6_CR85","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1021\/jo00087a020","volume":"59","author":"J Needham","year":"1994","unstructured":"Needham J, Kelly MT, Ishige M, Andemen RJ (1994) Andrimid and moiramides A-C, metabolites produced in culture by a marine isolate of the bacterium Pseudomonas fluorescens: structure elucidation and biosynthesis. J Org Chem 59:2058\u20132063","journal-title":"J Org Chem"},{"key":"6_CR86","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s00284-006-0345-6","volume":"54","author":"E Vasileva-Tonkova","year":"2007","unstructured":"Vasileva-Tonkova E, Gesheva V (2007) Biosurfactant production by Antarctic facultative anaerobe Pantoea sp. during growth on hydrocarbons. Curr Microbiol 54:136\u2013141","journal-title":"Curr Microbiol"},{"key":"6_CR87","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cbpa.2009.02.037","volume":"13","author":"HB Bode","year":"2009","unstructured":"Bode HB (2009) Entomopathogenic bacteria as a source of secondary metabolites. Curr Opin Chem Biol 13:224\u2013230","journal-title":"Curr Opin Chem Biol"},{"key":"6_CR88","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1021\/np800053n","volume":"71","author":"G Lang","year":"2008","unstructured":"Lang G, Kalvelage T, Peters A, Wiese J, Imhoff JF (2008) Linear and cyclic peptides from the entomopathogenic bacterium Xenorhabdus nematophilus. J Nat Prod 71:1074\u20131077","journal-title":"J Nat Prod"},{"key":"6_CR89","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1021\/np50075a006","volume":"54","author":"BV McInerney","year":"1991","unstructured":"McInerney BV, Taylor WC, Lacey MJ, Akhurst RJ, Gregson RP (1991) Biologically active metabolites from Xenorhabdus spp. Part 2. Benzopyran-1-one derivatives with gastroprotective activity. J Nat Prod 54:785\u2013795","journal-title":"J Nat Prod"},{"key":"6_CR90","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1139\/m97-110","volume":"43","author":"J Li","year":"1997","unstructured":"Li J, Chen G, Webster JM (1997) Nematophin a novel antimicrobial substance produced by Xenorhabdus nematophilus (Enterobactereaceae). Can J Microbiol 43:770\u2013773","journal-title":"Can J Microbiol"},{"key":"6_CR91","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1099\/ijs.0.65290-0","volume":"58","author":"JH Park","year":"2008","unstructured":"Park JH, Kim R, Aslam Z, Jeon CO, Chung YR (2008) Lysobacter capsici sp. nov., with antimicrobial activity, isolated from the rhizosphere of pepper, and emended description of the genus Lysobacter. Int J Syst Evol Microbiol 58:387\u2013392","journal-title":"Int J Syst Evol Microbiol"},{"key":"6_CR92","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/ejoc.201001695","volume":"2011","author":"F Kloss","year":"2011","unstructured":"Kloss F, Lincke T, Hertweck C (2011) Highly efficient total synthesis of the Clostridium-derived anti-MRSA antibiotic closthioamide. Eur J Org Chem 2011:1429\u20131431","journal-title":"Eur J Org Chem"},{"key":"6_CR93","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/ange.200906114","volume":"122","author":"T Lincke","year":"2010","unstructured":"Lincke T, Behnken S, Ishida K, Roth M, Hertweck C (2010) Closthioamide: an unprecedented polythioamide antibiotic from the strictly anaerobic bacterium Clostridium cellulolyticum. Angew Chem Int Ed 122:2055\u20132057","journal-title":"Angew Chem Int Ed"},{"key":"6_CR94","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ja.2008.30","volume":"61","author":"M Ezaki","year":"2008","unstructured":"Ezaki M, Muramatsu H, Takase S, Hashimoto M, Nagai K (2008) Naphthalecin, a novel antibiotic produced by the anaerobic bacterium, Sporotalea colonica sp. nov. J Antibiot 61:207\u2013212","journal-title":"J Antibiot"},{"key":"6_CR95","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1128\/AEM.66.10.4325-4333.2000","volume":"66","author":"MM Ganzle","year":"2000","unstructured":"Ganzle MM, Holtzel A, Walter J, Gunther J, Hammes WP (2000) Characterization of reutericyclin produced by Lactobacillus reuteri LTH2584. Appl Environ Microbiol 66:4325\u20134333","journal-title":"Appl Environ Microbiol"},{"key":"6_CR96","first-page":"5368","volume":"6","author":"JAS Salman","year":"2014","unstructured":"Salman JAS, Alimer DA (2014) Antibacterial and antiadhesive properties of a biosurfactant isolated from Lactobacillus rhamnosus against some bacteria causing UTI in Iraqi women. Int J Curr Res 6:5368\u20135374","journal-title":"Int J Curr Res"},{"key":"6_CR97","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00253-012-4285-8","volume":"96","author":"S Behnken","year":"2012","unstructured":"Behnken S, Hertweck C (2012) Anaerobic bacteria as producers of antibiotics. Appl Microbiol Biotechnol 96:61\u201367","journal-title":"Appl Microbiol Biotechnol"},{"key":"6_CR98","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1039\/C2NP20103H","volume":"30","author":"AC Letzel","year":"2013","unstructured":"Letzel AC, Pidot SJ, Hertweck C (2013) A genomic approach to the cryptic secondary metabolome of the anaerobic world. Nat Prod Rep 30:392\u2013428","journal-title":"Nat Prod Rep"},{"key":"6_CR99","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1073\/pnas.0711093105","volume":"105","author":"H Seedorf","year":"2008","unstructured":"Seedorf H, Fricke WF, Veith B, Bruggemann H, Liesegang H, Strittmatter A, Miethke M, Buckel W, Hinderberger J, Li F, Hagemeier C, Thauer RK, Gottschalk G (2008) The genome of Clostridium kluyveri, a strict anaerobe with unique metabolic features. Proc Natl Acad Sci U S A 105:2128\u20132133","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6_CR100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029609","volume":"7","author":"S Behnken","year":"2012","unstructured":"Behnken S, Hertweck C (2012) Cryptic polyketide synthase genes in non-pathogenic Clostridium spp. PLoS One 7(1), e29609","journal-title":"PLoS One"},{"key":"6_CR101","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/1574-6968.12457","volume":"355","author":"J Zhang","year":"2014","unstructured":"Zhang J, Liangcheng D, Liu F, Xu F, Hu B, Venturi V, Qian G (2014) Involvement of both PKS and NRPS in antibacterial activity in Lysobacter enzymogenes OH11. FEMS Microbiol Lett 355:170\u2013176","journal-title":"FEMS Microbiol Lett"},{"key":"6_CR102","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1039\/b821578b","volume":"7","author":"K Scherlach","year":"2009","unstructured":"Scherlach K, Hertweck C (2009) Triggering cryptic natural product biosynthesis in microorganisms. Org Biomol Chem 7:1753\u20131760","journal-title":"Org Biomol Chem"},{"key":"6_CR103","first-page":"83","volume":"58","author":"DG Cooper","year":"1980","unstructured":"Cooper DG, Zajic JE, Gerson DF, Manninen KI (1980) Isolation and identification of biosurfactants produced during anaerobic growth of Clostridium pasteurianum. J Ferment Technol 58:83\u201386","journal-title":"J Ferment Technol"},{"key":"6_CR104","doi-asserted-by":"crossref","first-page":"444S","DOI":"10.1093\/ajcn\/73.2.444s","volume":"73","author":"E Isolauri","year":"2001","unstructured":"Isolauri E, S\u00fctas Y, Kankaanp\u00e4\u00e4 P, Arvilommi H, Salminen S (2001) Probiotics: effects on immunity. Am J Clin Nutr 73:444S\u2013450S","journal-title":"Am J Clin Nutr"},{"key":"6_CR105","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1177\/0148607112467819","volume":"37","author":"H Akatsu","year":"2013","unstructured":"Akatsu H, Iwabuchi N, Xiao JZ, Matsuyama Z, Kurihara R, Okuda K, Yamamoto T, Maruyama M (2013) Clinical effects of probiotic Bifidobacterium longum BB536 on immune function and intestinal microbiota in elderly patients receiving enteral tube feeding. J Parenter Enteral Nutr 37:631\u2013640","journal-title":"J Parenter Enteral Nutr"},{"key":"6_CR106","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ajcn\/74.6.833","volume":"74","author":"HS Gill","year":"2001","unstructured":"Gill HS, Rutherfurd KJ, Cross ML, Gopal PK (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74:833\u2013839","journal-title":"Am J Clin Nutr"},{"key":"6_CR107","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/01.ta.0000197374.99755.fe","volume":"60","author":"K Shimizu","year":"2006","unstructured":"Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, Yoshiya K, Matsushima A, Sumi Y, Kuwagata Y, Tanaka H, Shimazu T, Sugimoto H (2006) Altered gut flora and environment in patients with severe SIRS. J Trauma 60:126\u2013133","journal-title":"J Trauma"},{"key":"6_CR108","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2005.05.007","volume":"122","author":"SK Mazmanian","year":"2005","unstructured":"Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107\u2013118","journal-title":"Cell"},{"key":"6_CR109","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2741\/3603","volume":"15","author":"EB Troy","year":"2010","unstructured":"Troy EB, Kasper DL (2010) Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Front Biosci 15:25\u201334","journal-title":"Front Biosci"},{"key":"6_CR110","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.4049\/jimmunol.1001443","volume":"185","author":"J Ochoa-Reparaz","year":"2010","unstructured":"Ochoa-Reparaz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S, Kasper D, Kasper L (2010) Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol 185:4101\u20134108","journal-title":"J Immunol"},{"key":"6_CR111","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/mi.2010.29","volume":"3","author":"J Ochoa-Reparaz","year":"2010","unstructured":"Ochoa-Reparaz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, Kasper D, Kasper L (2010) A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol 3:487\u2013495","journal-title":"Mucosal Immunol"},{"key":"6_CR112","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/ncomms2478","volume":"4","author":"YK Mao","year":"2013","unstructured":"Mao YK, Kasper DL, Wang B, Forsythe P, Bienenstock J, Kunze WA (2013) Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat Commun 4:1465. doi: 10.1038\/ncomms2478","journal-title":"Nat Commun"},{"key":"6_CR113","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/sj.embor.7400731","volume":"7","author":"AM O\u2019Hara","year":"2006","unstructured":"O\u2019Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7:688\u2013693","journal-title":"EMBO Rep"},{"key":"6_CR114","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jnutbio.2009.06.001","volume":"20","author":"CD Davis","year":"2009","unstructured":"Davis CD, Milner JA (2009) Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem 20:743\u2013752","journal-title":"J Nutr Biochem"},{"key":"6_CR115","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijfoodmicro.2011.05.025","volume":"152","author":"EF O\u2019Shea","year":"2012","unstructured":"O\u2019Shea EF, Cotter PD, Stanton C, Ross RP, Hill C (2012) Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid. Int J Food Microbiol 152:189\u2013205","journal-title":"Int J Food Microbiol"},{"key":"6_CR116","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1006\/phrs.2000.0735","volume":"42","author":"D Leah","year":"2000","unstructured":"Leah D, Whigham LD, Mark E, Cook ME, Richard L, Atkinson RL (2000) Conjugated linoleic acid: implications for human health. Pharmacol Res 42:503\u2013510","journal-title":"Pharmacol Res"},{"key":"6_CR117","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.clnu.2012.03.002","volume":"31","author":"J Bassaganya-Riera","year":"2012","unstructured":"Bassaganya-Riera J, Hontecillas R, Horne WT, Sandridge M, Herfarth HH, Bloomfeld R, Isaacs KL (2012) Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn\u2019s disease. Clin Nutr 31:721\u2013727","journal-title":"Clin Nutr"},{"key":"6_CR118","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1021\/jf0730789","volume":"56","author":"SH Chung","year":"2008","unstructured":"Chung SH, Kim IH, Park HG, Kang HS, Yoon CS, Jeong HY, Choi NJ, Kwon EG, Kim YJ (2008) Synthesis of conjugated linoleic acid by human-derived Bifidobacterium breve LMC 017: utilization as a functional starter culture for milk fermentation. J Agric Food Chem 56:3311\u20133316","journal-title":"J Agric Food Chem"},{"key":"6_CR119","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1046\/j.1365-2672.1998.00481.x","volume":"85","author":"J Jiang","year":"1998","unstructured":"Jiang J, Bjorck L, Fonden R (1998) Production of conjugated linoleic acid by dairy starter cultures. J Appl Microbiol 85:95\u2013102","journal-title":"J Appl Microbiol"},{"key":"6_CR120","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1263\/jbb.100.355","volume":"100","author":"J Ogawa","year":"2005","unstructured":"Ogawa J, Kishino S, Ando A, Sugimoto S, Mihara K, Shimizu S (2005) Production of conjugated fatty acids by lactic acid bacteria. J Biosci Bioeng 100:355\u2013364","journal-title":"J Biosci Bioeng"},{"issue":"4","key":"6_CR121","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00394-008-0710-2","volume":"47","author":"NP M\u00f6ller","year":"2008","unstructured":"M\u00f6ller NP, Scholz-Arhens KE, Roos N, Sherezenmeir J (2008) Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr 47(4):171\u2013182","journal-title":"Eur J Nutr"},{"key":"6_CR122","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2174\/1381612033454892","volume":"9","author":"H Korhonen","year":"2003","unstructured":"Korhonen H, Pihlanto A (2003) Food-derived bioactive peptides \u2013 opportunities for designing future foods. Curr Pharm Des 9:1297\u20131308","journal-title":"Curr Pharm Des"},{"key":"6_CR123","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2174\/1381612033454847","volume":"9","author":"H Meisel","year":"2003","unstructured":"Meisel H, FitzGerald RJ (2003) Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Des 9:1289\u20131295","journal-title":"Curr Pharm Des"},{"key":"6_CR124","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s13594-013-0152-3","volume":"94","author":"V Raikos","year":"2014","unstructured":"Raikos V, Dassios T (2014) Health-promoting properties of bioactive peptides derived from milk proteins in infant food: a review. Dairy Sci Technol 94:91\u2013101","journal-title":"Dairy Sci Technol"},{"key":"6_CR125","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1471-0307.2004.00139.x","volume":"57","author":"M Gobbetti","year":"2004","unstructured":"Gobbetti M, Minervini F, Rizzello CG (2004) Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides. Int J Dairy Technol 57:173\u2013188","journal-title":"Int J Dairy Technol"},{"key":"6_CR126","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2174\/1381612033454892","volume":"9","author":"H Korhonen","year":"2001","unstructured":"Korhonen H, Pihlanto A (2001) Food-derived bioactive peptides \u2013 opportunities for designing future foods. Curr Pharm Des 9:1297\u20131308","journal-title":"Curr Pharm Des"},{"key":"6_CR127","first-page":"177","volume-title":"Handbook of fermented functional foods. Functional foods and nutraceuticals series","author":"C Matar","year":"2003","unstructured":"Matar C, LeBlanc JG, Martin L, Perdig\u00f3n G (2003) Biologically active peptides released in fermented milk: role and functions. In: Farnworth ER (ed) Handbook of fermented functional foods. Functional foods and nutraceuticals series. CRC Press, Florida, pp 177\u2013201"},{"key":"6_CR128","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1089\/jmf.2012.2541","volume":"16","author":"T Nakamura","year":"2013","unstructured":"Nakamura T, Hirota T, Mizushima K, Ohki K, Naito Y, Yamamoto N, Yoshikawa T (2013) Milk-derived peptides, Val-Pro-Pro and Ile-Pro-Pro, attenuate atherosclerosis development in apolipoprotein E-deficient mice: a preliminary study. J Med Food 16:396\u2013403","journal-title":"J Med Food"},{"key":"6_CR129","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1472-765X.2004.01560.x","volume":"39","author":"K Ueno","year":"2004","unstructured":"Ueno K, Mizuno S, Yamamoto N (2004) Purification and characterization of an endopeptidase that has an important role in the carboxyl terminal processing of antihypertensive peptides in Lactobacillus helveticus CM4. Lett Appl Microbiol 39:313\u2013318","journal-title":"Lett Appl Microbiol"},{"key":"6_CR130","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1082013211398801","volume":"17","author":"CM Urista","year":"2011","unstructured":"Urista CM, Fernandez RA, Rodriguez FR, Cuenca AA, Jurado AT (2011) Review: production and functionality of active peptides from milk. Food Sci Technol Int 17:293\u2013317","journal-title":"Food Sci Technol Int"},{"key":"6_CR131","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/gme.0b013e3181f85aa7","volume":"18","author":"Y Tousen","year":"2011","unstructured":"Tousen Y, Ezaki J, Fujii Y, Ueno T, Nishimuta M, Ishimi Y (2011) Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: a pilot randomized, placebo-controlled trial. Menopause 18:563\u2013574","journal-title":"Menopause"},{"key":"6_CR132","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/gme.0b013e3180305299","volume":"14","author":"J Wu","year":"2007","unstructured":"Wu J, Oka J, Ezaki J, Ohtomo T, Ueno T, Uchiyama S, Toda T, Uehara M, Ishimi Y (2007) Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause 14:866\u2013874","journal-title":"Menopause"},{"key":"6_CR133","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/jjco\/hyh015","volume":"34","author":"H Akaza","year":"2004","unstructured":"Akaza H, Miyanaga N, Takashima N et al (2004) Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34:86\u201389","journal-title":"Jpn J Clin Oncol"},{"key":"6_CR134","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1095\/biolreprod.103.023713","volume":"70","author":"TD Lund","year":"2004","unstructured":"Lund TD, Munson DJ, Haldy ME, Setchell KD, Lephart ED, Handa RJ (2004) Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod 70:1188\u20131195","journal-title":"Biol Reprod"},{"key":"6_CR135","doi-asserted-by":"crossref","unstructured":"Esp\u00edn JC, Larrosa M, Garc\u00eda-Conesa MT, Tom\u00e1s-Barber\u00e1n F (2013) Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far. Evid Based Complement Alternat Med, http:\/\/dx.doi.org\/10.1155\/2013\/270418","DOI":"10.1155\/2013\/270418"},{"key":"6_CR136","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1097\/00008469-199703001-00009","volume":"6","author":"MJ Hill","year":"1997","unstructured":"Hill MJ (1997) Intestinal flora and endogenous vitamin synthesis. Eur J Cancer Prev 6:S43\u2013S45","journal-title":"Eur J Cancer Prev"},{"key":"6_CR137","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2174\/138161209788168128","volume":"15","author":"DM Saulnier","year":"2009","unstructured":"Saulnier DM, Kolida S, Gibson GR (2009) Microbiology of the human intestinal tract and approaches for its dietary modulation. Curr Pharm Des 15:1403\u20131414","journal-title":"Curr Pharm Des"},{"key":"6_CR138","first-page":"83","volume":"2","author":"S Jayashree","year":"2010","unstructured":"Jayashree S, Jayaraman K, Kalaichelvan G (2010) Isolation, screening and characterization of riboflavin producing lactic acid bacteria from Katpadi, Vellore district. Recent Res Sci Technol 2:83\u201388","journal-title":"Recent Res Sci Technol"},{"key":"6_CR139","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/1082013206073274","volume":"12","author":"G Papastoyiannidis","year":"2006","unstructured":"Papastoyiannidis G, Polychroniadou A, Michaelidou AM, Alichanidis E (2006) Fermented milks fortified with B-group vitamins: vitamin stability and effect on resulting products. Food Sci Technol Int 12:521\u2013529","journal-title":"Food Sci Technol Int"},{"key":"6_CR140","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1128\/AEM.02719-07","volume":"74","author":"F Santos","year":"2008","unstructured":"Santos F, Wegkamp A, de Vos WM, Smid EJ, Hugenholtz J (2008) High-level folate production in fermented foods by the B12 producer Lactobacillus reuteri JCM1112. Appl Environ Microbiol 74:3291\u20133294","journal-title":"Appl Environ Microbiol"},{"key":"6_CR141","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.1124234","volume":"312","author":"SR Gill","year":"2006","unstructured":"Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE (2006) Metagenomic analysis of the human distal gut microbiome. Science 312:1355\u20131359","journal-title":"Science"},{"key":"6_CR142","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/01.mog.0000203870.22706.52","volume":"22","author":"HM Said","year":"2006","unstructured":"Said HM, Mohammed ZM (2006) Intestinal absorption of water-soluble vitamins: an update. Curr Opin Gastroenterol 22:140\u2013146","journal-title":"Curr Opin Gastroenterol"},{"key":"6_CR143","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jn\/122.3.506","volume":"122","author":"T Ichihashi","year":"1992","unstructured":"Ichihashi T, Takagishi Y, Uchida K, Yamada H (1992) Colonic absorption of menaquinone-4 and menaquinone-9 in rats. J Nutr 122:506\u2013512","journal-title":"J Nutr"},{"key":"6_CR144","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijfoodmicro.2015.04.033","volume":"206","author":"Q Gu","year":"2015","unstructured":"Gu Q, Zhang C, Song D, Li P, Zhu X (2015) Enhancing vitamin B 12 content in soy-yogurt by Lactobacillus reuteri. Int J food Microbiol 206:56\u201359","journal-title":"Int J food Microbiol"},{"key":"6_CR145","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/nu3010118","volume":"3","author":"M Rossi","year":"2011","unstructured":"Rossi M, Amaretti A, Raimondi S (2011) Folate production by probiotic bacteria. Nutrients 3:118\u2013134","journal-title":"Nutrients"},{"key":"6_CR146","first-page":"74","volume":"5","author":"EE Chukwu","year":"2014","unstructured":"Chukwu EE, Nwaokorie FO, Coker AO (2014) Role of anaerobes as probiotic organisms. Int J Food Nutr Saf 5:74\u201397","journal-title":"Int J Food Nutr Saf"},{"key":"6_CR147","first-page":"143","volume":"8","author":"JA Drisko","year":"2003","unstructured":"Drisko JA, Giles CK, Bischoff BJ (2003) Probiotics in health maintenance and disease prevention. Altern Med Rev 8:143\u2013155","journal-title":"Altern Med Rev"},{"key":"6_CR148","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jmii.2013.03.010","volume":"47","author":"A Patel","year":"2014","unstructured":"Patel A, Shah N, Prajapati JB (2014) Clinical application of probiotics in the treatment of Helicobacter pylori infection \u2013 a brief review. J Microbiol Immunol Infect 47:429\u2013437","journal-title":"J Microbiol Immunol Infect"},{"volume-title":"Probiotics: the scientific basis","year":"2012","key":"6_CR149","unstructured":"Fuller R (ed) (2012) Probiotics: the scientific basis. Springer Science, Netherlands"},{"key":"6_CR150","doi-asserted-by":"publisher","DOI":"10.1007\/10_2016_14","author":"H El-Henshasy","year":"2016","unstructured":"El-Henshasy H, Malik K, AbdMalek R, Othman NZ, Elsayed EA, Wadaan M (2016) Anaerobic probiotics: the key microbes for human health. Adv Biochem Eng Biotechnol. doi: 10.1007\/10_2016_14","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"6_CR151","first-page":"1408","volume":"58","author":"JM Brown","year":"1998","unstructured":"Brown JM, Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58:1408\u20131416","journal-title":"Cancer Res"},{"key":"6_CR152","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1259\/bjr\/12913493","volume":"76","author":"N Raghunand","year":"2014","unstructured":"Raghunand N, Gatenby RA, Gillies RJ (2014) Microenvironmental and cellular consequences of altered blood flow in tumours. Br J Radiol 76:S11\u2013S22","journal-title":"Br J Radiol"},{"key":"6_CR153","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/339058a0","volume":"339","author":"J Folkman","year":"1989","unstructured":"Folkman J, Watson K, Ingber D, Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58\u201361","journal-title":"Nature"},{"key":"6_CR154","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00253-011-3695-3","volume":"93","author":"CH Lee","year":"2012","unstructured":"Lee CH (2012) Engineering bacteria toward tumor targeting for cancer treatment: current state and perspectives. Appl Microbiol Biotechnol 93:517\u2013523","journal-title":"Appl Microbiol Biotechnol"},{"key":"6_CR155","first-page":"173","volume":"3","author":"ME Fox","year":"1996","unstructured":"Fox ME, Lemmon MJ, Mauchline ML, Davis TO, Giaccia AJ, Minton NP, Brown JM (1996) Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther 3:173\u2013178","journal-title":"Gene Ther"},{"key":"6_CR156","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/anae.1998.0161","volume":"4","author":"P Lambin","year":"1998","unstructured":"Lambin P, Theys J, Landuyt W, Rijken R, van der Kogel A, van der Schueren E, Hodgkiss R, Fowler J, Nuyts S, de Bruijn E, Van Mellaert L, Ann\u00e9 J (1998) Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours. Anaerobe 4:183\u2013188","journal-title":"Anaerobe"},{"key":"6_CR157","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00001813-200202000-00002","volume":"13","author":"S Nuyts","year":"2002","unstructured":"Nuyts S, Van Mellaert L, Theys J, Landuyt W, Lambin P, Anne J (2002) Clostridium spores for tumor-specific drug delivery. Anticancer Drugs 13:115\u2013125","journal-title":"Anticancer Drugs"},{"key":"6_CR158","first-page":"548","volume":"25","author":"J Theys","year":"2001","unstructured":"Theys J, Landuyt AW, Nuyts S, Van Mellaert L, Lambin P, Anne J (2001) Clostridium as a tumor-specific delivery system of therapeutic proteins. Cancer Detect Prev 25:548\u2013557","journal-title":"Cancer Detect Prev"},{"key":"6_CR159","first-page":"37","volume":"17","author":"KB Low","year":"1999","unstructured":"Low KB, Ittensohn M, Le T, Platt J, Sodi S, Amoss M, Ash O, Carmichael E, Chakraborty A, Fischer J et al (1999) Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol 17:37\u201341","journal-title":"Nat Biotechnol"},{"key":"6_CR160","first-page":"4537","volume":"57","author":"JM Pawelek","year":"1997","unstructured":"Pawelek JM, Low KB, Bermudes D (1997) Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 57:4537\u20134544","journal-title":"Cancer Res"},{"key":"6_CR161","first-page":"200","volume":"5","author":"M Fujimori","year":"2002","unstructured":"Fujimori M, Amano J, Taniguchi S (2002) The genus Bifidobacterium for cancer gene therapy. Curr Opin Drug Discov Devel 5:200\u2013203","journal-title":"Curr Opin Drug Discov Devel"},{"key":"6_CR162","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1023\/A:1010644217648","volume":"66","author":"K Yazawa","year":"2001","unstructured":"Yazawa K, Fujimori M, Nakamura T, Sasaki T, Amano J, Kano Y, Taniguchi S (2001) Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Res Treat 66:165\u2013170","journal-title":"Breast Cancer Res Treat"},{"key":"6_CR163","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nbt937","volume":"22","author":"YA Yu","year":"2004","unstructured":"Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I, Goebel R, Szalay AA (2004) Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 22:313\u2013320","journal-title":"Nat Biotechnol"},{"key":"6_CR164","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.copbio.2008.08.004","volume":"19","author":"ATS Jean","year":"2008","unstructured":"Jean ATS, Zhang M, Forbes NS (2008) Bacterial therapies: completing the cancer treatment toolbox. Curr Opin Biotechnol 19:511\u2013517","journal-title":"Curr Opin Biotechnol"},{"key":"6_CR165","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.cgt.7700634","volume":"10","author":"J Nemunaitis","year":"2003","unstructured":"Nemunaitis J, Cunningham C, Senzer N, Kuhn J, Cramm J, Litz C, Cavagnolo R, Cahill A, Clairmont C, Sznol M (2003) Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer Gene Ther 10:737\u2013744","journal-title":"Cancer Gene Ther"},{"key":"6_CR166","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F et al (2002) Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 20:142\u2013152","journal-title":"J Clin Oncol"},{"key":"6_CR167","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrmicro777","volume":"1","author":"NP Minton","year":"2003","unstructured":"Minton NP (2003) Clostridia in cancer therapy. Nat Rev Microbiol 1:237\u2013242","journal-title":"Nat Rev Microbiol"},{"key":"6_CR168","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2325\/jbcs.13.27","volume":"13","author":"M Fujimori","year":"2006","unstructured":"Fujimori M (2006) Genetically engineered Bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. Breast Cancer 13:27\u201331","journal-title":"Breast Cancer"},{"key":"6_CR169","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1158\/0008-5472.CAN-06-2618","volume":"67","author":"RW Kasinskas","year":"2007","unstructured":"Kasinskas RW, Forbes NS (2007) Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. Cancer Res 67:3201\u20133209","journal-title":"Cancer Res"},{"key":"6_CR170","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.gt.3301659","volume":"9","author":"SC Liu","year":"2002","unstructured":"Liu SC, Minton NP, Giaccia AJ, Brown JM (2002) Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia\/necrosis. Gene Ther 9:291\u2013296","journal-title":"Gene Ther"},{"key":"6_CR171","first-page":"S21","volume":"3","author":"J Theys","year":"2015","unstructured":"Theys J, Lambin P (2015) Clostridium to treat cancer: dream or reality? Ann Transl Med 3:S21","journal-title":"Ann Transl Med"},{"key":"6_CR172","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/mt.2014.36","volume":"22","author":"ATS Jean","year":"2014","unstructured":"Jean ATS, Swofford CA, Panteli JT, Brentzel ZJ, Forbes NS (2014) Bacterial delivery of Staphylococcus aureus \u03b1-hemolysin causes regression and necrosis in murine tumors. Mol Ther 22:1266\u20131274","journal-title":"Mol Ther"},{"key":"6_CR173","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/lam.12436","volume":"61","author":"S Wong","year":"2015","unstructured":"Wong S, Slavcev RA (2015) Treating cancer with infection: a review on bacterial cancer therapy. Lett Appl Microbiol 61:107\u2013112","journal-title":"Lett Appl Microbiol"},{"key":"6_CR174","doi-asserted-by":"publisher","first-page":"289ra84","DOI":"10.1126\/scitranslmed.aaa3519","volume":"7","author":"T Danino","year":"2015","unstructured":"Danino T, Prindle A, Kwong GA, Skalak M, Li H, Allen K, Hasty J, Bhatia SN (2015) Programmable probiotics for detection of cancer in urine. Sci Transl Med 7:289ra84","journal-title":"Sci Transl Med"},{"key":"6_CR175","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ajgsup.2012.7","volume":"1","author":"Y Ringel","year":"2012","unstructured":"Ringel Y, Quigley EMM, Lin HC (2012) Using probiotics in gastrointestinal disorders. Am J Gastroenterol Suppl 1:34\u201340","journal-title":"Am J Gastroenterol Suppl"},{"key":"6_CR176","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/cid\/cir632","volume":"53","author":"E Gough","year":"2011","unstructured":"Gough E, Shaikh H, Manges AR (2011) Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53:994\u20131002","journal-title":"Clin Infect Dis"},{"key":"6_CR177","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2011.244","volume":"9","author":"TJ Borody","year":"2012","unstructured":"Borody TJ, Khoruts A (2012) Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 9:88\u201396","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6_CR178","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/MOG.0b013e32835a4b3e","volume":"29","author":"OC Aroniadis","year":"2013","unstructured":"Aroniadis OC, Brandt LJ (2013) Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol 29:79\u201384","journal-title":"Curr Opin Gastroenterol"},{"key":"6_CR179","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.crohns.2014.08.006","volume":"8","author":"RJ Colman","year":"2014","unstructured":"Colman RJ, Rubin DT (2014) Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohn\u2019s Colitis 8:1569\u20131581","journal-title":"J Crohn\u2019s Colitis"},{"key":"6_CR180","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/S0016-5085(99)70029-6","volume":"116","author":"M Campieri","year":"1999","unstructured":"Campieri M, Gionchetti P (1999) Probiotics in inflammatory bowel disease: new insights to pathogenesis or a possible therapeutic alternative. Gastroenterology 116:1246\u20131249","journal-title":"Gastroenterology"},{"key":"6_CR181","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/003655201753265082","volume":"234","author":"RK Linskens","year":"2001","unstructured":"Linskens RK, Huijsdens XW, Savelkoul PH, Vandenbroucke-Grauls CM, Meuwissen SG (2001) The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl 234:29\u201340","journal-title":"Scand J Gastroenterol Suppl"},{"key":"6_CR182","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0016-5085(84)90606-1","volume":"86","author":"GL Simon","year":"1984","unstructured":"Simon GL, Gorbach SL (1984) Intestinal flora in health and disease. Gastroenterology 86:174\u2013193","journal-title":"Gastroenterology"},{"key":"6_CR183","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.1073\/pnas.95.12.6578","volume":"95","author":"WB Whitman","year":"1998","unstructured":"Whitman WB, Coleman DC, Wiebe WJ (1998) Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A 95:6578\u20136583","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR184","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1651-2227.2003.tb00646.x","volume":"91","author":"S Fanaro","year":"2003","unstructured":"Fanaro S, Chierici R, Guerrini P, Vigi V (2003) Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 91:48\u201355","journal-title":"Acta Paediatr Suppl"},{"key":"6_CR185","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1128\/AEM.02063-08","volume":"75","author":"R Martin","year":"2009","unstructured":"Martin R, Jimenez E, Heilig H, Fernandez L, Marin ML, Zoetendal EG, Rodriguez JM (2009) Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol 75:965\u2013969","journal-title":"Appl Environ Microbiol"},{"key":"6_CR186","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1110591","volume":"308","author":"PB Eckburg","year":"2005","unstructured":"Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308:1635\u20131638","journal-title":"Science"},{"key":"6_CR187","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cell.2006.02.017","volume":"124","author":"RE Ley","year":"2006","unstructured":"Ley RE, Peterson DA, Gordon JI (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:837\u2013848","journal-title":"Cell"},{"key":"6_CR188","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S1369-5274(99)00055-7","volume":"3","author":"LV Hooper","year":"2000","unstructured":"Hooper LV, Falk PG, Gordon JI (2000) Analyzing the molecular foundations of commensalism in the mouse intestine. Curr Opin Microbiol 3:79\u201385","journal-title":"Curr Opin Microbiol"},{"key":"6_CR189","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.nutr.22.011602.092259","volume":"22","author":"LV Hooper","year":"2002","unstructured":"Hooper LV, Midtvedt T, Gordon JI (2002) How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22:283\u2013307","journal-title":"Annu Rev Nutr"},{"key":"6_CR190","doi-asserted-by":"publisher","first-page":"15718","DOI":"10.1073\/pnas.0407076101","volume":"101","author":"F Backhed","year":"2004","unstructured":"Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101:15718\u201315723","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR191","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/msb.2008.56","volume":"4","author":"SP Claus","year":"2008","unstructured":"Claus SP, Tsang TM, Wang Y, Cloarec O, Skordi E, Martin FP, Rezzi S, Ross A, Kochhar S, Holmes E, Nicholson JK (2008) Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol 4:219","journal-title":"Mol Syst Biol"},{"key":"6_CR192","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.1073\/pnas.0700440104","volume":"104","author":"SC Corr","year":"2007","unstructured":"Corr SC, Li Y, Riedel CU, O\u2019Toole PW, Hill C, Gahan CG (2007) Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A 104:7617\u20137621","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR193","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1099\/jmm.0.05009-0","volume":"52","author":"YK Lee","year":"2003","unstructured":"Lee YK, Puong KY, Ouwehand AC, Salminen S (2003) Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J Med Microbiol 52:925\u2013930","journal-title":"J Med Microbiol"},{"key":"6_CR194","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nri1373","volume":"4","author":"AJ Macpherson","year":"2004","unstructured":"Macpherson AJ, Harris NL (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4:478\u2013485","journal-title":"Nat Rev Immunol"},{"key":"6_CR195","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1021\/pr100554m","volume":"9","author":"FP Martin","year":"2010","unstructured":"Martin FP, Sprenger N, Montoliu I, Rezzi S, Kochhar S, Nicholson JK (2010) Dietary modulation of gut functional ecology studied by fecal metabonomics. J Proteome Res 9:5284\u20135295","journal-title":"J Proteome Res"},{"key":"6_CR196","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/msb.2008.40","volume":"4","author":"FP Martin","year":"2008","unstructured":"Martin FP, Wang Y, Sprenger N, Yap IK, Rezzi S, Ramadan Z, Pere-Trepat E, Rochat F, Cherbut C, van Bladeren P, Fay LB, Kochhar S, Lindon JC, Holmes E, Nicholson JK (2008) Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model. Mol Syst Biol 4:205","journal-title":"Mol Syst Biol"},{"key":"6_CR197","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.tim.2004.10.008","volume":"12","author":"MC Noverr","year":"2004","unstructured":"Noverr MC, Huffnagle GB (2004) Does the microbiota regulate immune responses outside the gut? Trends Microbiol 12:562\u2013568","journal-title":"Trends Microbiol"},{"key":"6_CR198","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ni1526","volume":"8","author":"EG Pamer","year":"2007","unstructured":"Pamer EG (2007) Immune responses to commensal and environmental microbes. Nat Immunol 8:1173\u20131178","journal-title":"Nat Immunol"},{"issue":"Suppl 1","key":"6_CR199","first-page":"4607","volume":"108","author":"JM Wells","year":"2010","unstructured":"Wells JM, Rossi O, Meijerink M, van Baarlen P (2010) Microbes and health sackler colloquium: epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A 108(Suppl 1):4607\u20134614","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR200","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1128\/JCM.00312-06","volume":"44","author":"PD Scanlan","year":"2006","unstructured":"Scanlan PD, Shanahan F, O\u2019Mahony C, Marchesi JR (2006) Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn\u2019s disease. J Clin Microbiol 44:3980\u20133988","journal-title":"J Clin Microbiol"},{"key":"6_CR201","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/cea.12253","volume":"44","author":"TR Abrahamsson","year":"2013","unstructured":"Abrahamsson TR, Jakobsson HE, Andersson AF, Bj\u00f6rksten B, Engstrand L, Jenmalm MC (2013) Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy 44:842\u2013850","journal-title":"Clin Exp Allergy"},{"key":"6_CR202","doi-asserted-by":"publisher","first-page":"307ra152","DOI":"10.1126\/scitranslmed.aab2271","volume":"7","author":"MC Arrieta","year":"2015","unstructured":"Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, Kuzeljevic B, Gold MJ, Britton HM, Lefebvre DL, Subbarao P, Mandhane P, Becker A, McNagny KM, Sears MR, Kollmann T, Mohn WW, Turvey SE, Finlay BB (2015) Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 7:307ra152. doi: 10.1126\/scitranslmed.aab2271","journal-title":"Sci Transl Med"},{"issue":"178","key":"6_CR203","doi-asserted-by":"publisher","first-page":"178ra41","DOI":"10.1126\/scitranslmed.3005687","volume":"5","author":"AP Liou","year":"2013","unstructured":"Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ, Kaplan LM (2013) Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 5(178):178ra41. doi: 10.1126\/scitranslmed.3005687","journal-title":"Sci Transl Med"},{"key":"6_CR204","first-page":"26164","volume":"26","author":"D Graf","year":"2015","unstructured":"Graf D, Di Cagno R, F\u00e5k F, Flint HJ, Nyman M, Saarela M, Watzl B (2015) Contribution of diet to the composition of the human gut microbiota. Microb Ecol Health Dis 26:26164, http:\/\/dx.doi.org\/10.3402\/mehd.v26.26164","journal-title":"Microb Ecol Health Dis"},{"key":"6_CR205","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1172\/JCI72333","volume":"124","author":"SR Modi","year":"2015","unstructured":"Modi SR, Collins JJ, Relman DA (2015) Antibiotics and the gut microbiota. J Clin Invest 124:4212\u20134218","journal-title":"J Clin Invest"}],"container-title":["Advances in Biochemical Engineering\/Biotechnology","Anaerobes in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/10_2016_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T08:21:44Z","timestamp":1718698904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/10_2016_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319456492","9783319456515"],"references-count":205,"URL":"https:\/\/doi.org\/10.1007\/10_2016_6","relation":{},"ISSN":["0724-6145","1616-8542"],"issn-type":[{"type":"print","value":"0724-6145"},{"type":"electronic","value":"1616-8542"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"19 July 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}